Amneal Pharmaceuticals, LLC

Form 483 issued February 21, 2019 · Branchburg, New Jersey

Inspection
Feb 5 – Feb 21, 2019
Observations
3
Pages
5
FEI number
3004488497

In short: On February 21, 2019, FDA issued a Form 483 with 3 observations to Amneal Pharmaceuticals, LLC in Branchburg, New Jersey (FEI 3004488497) after an inspection that ran Feb 5 – Feb 21, 2019. The investigator was James R. Birkenstamm. Most observations concern quality system and materials.

At a glance

Quality system and materials account for 2 of 3 observations.

Quality system1
Materials1
Facilities & equipment1

What FDA observed

Preview: the opening words of each observation
  1. 01

    There is a failure to thoroughly review any unexplained discrepancy and the failure of a batch…

  2. 02

    Reports of analysis from component suppliers are accepted in lieu of testing each component for conformity…

  3. 03

    Separate or defined areas to prevent contamination or mix-ups are deficient regarding operations related to the…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Amneal Pharmaceuticals, LLC?

FDA listed 3 observations on this Form 483, mostly about quality system, materials and facilities & equipment. The opening words of each observation are shown on this page.

Who inspected Amneal Pharmaceuticals, LLC?

James R. Birkenstamm is named on this Form 483, for the inspection of Feb 5 – Feb 21, 2019. Each investigator has a profile showing what they cite most.

When was Amneal Pharmaceuticals, LLC inspected by FDA?

The inspection ran Feb 5 – Feb 21, 2019, and the Form 483 is dated February 21, 2019.

How do I get the full Form 483 for Amneal Pharmaceuticals, LLC?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free